Lifespan.io Launches Lifespan News
Brent Nally, in this first episode of Lifespan News discusses Unity Biotechnology’s human trials of novel senolytics, including a phase 2 human trial for knee osteoarthritis. He also talks about Ponce de Leon Health’s epigenetic age reversal, the reason naked mole-rats are resistant to cancer, XPrize’s addition of longevity to their impact roadmaps, and a promotional code for our upcoming online event, Ending Age Related Diseases 2020.
You can get your ticket to EARD2020 at https://www.eventbrite.com/e/ending-age-related-diseases-202…4918805703
Introduction
Unity Biotechnology Updates – 0:51
1:43 Proteins & LDL: https://www.lifespan.io/news/two-proteins-allow-ldl-cholesterol-into-our-cells/
2:17 Epigenetic Age Reversal: https://www.lifespan.io/news/pilot-study-results-suggest-epi…-reversal/
318 Naked Mole Rat
4:11 XPrize and Longevity: https://www.xprize.org/articles/future-of-longevity-blog-post
4:50 Additional Information & Outro
How can you support us?
##########################
LEAF/Lifespan.io operates as a nonprofit 501(c). We are grateful for your support. Please stand with us as we fight diseases of aging.
> Support us with monthly donations by becoming a Lifespan Hero: https://www.lifespan.io/hero
> Make a one-time donation and learn about other ways to support us here: http://lifespan.io/support
> Learn more, and help us #CrowdsourceTheCure: https://www.lifespan.io
> Subscribe: https://www.youtube.com/user/LifespanIO
#LifespanNews #LifespanIO #Unity #XPrize #Senolytics
Source:
